Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer

Open access
Guillén Díaz-Maroto, Natalia, Sanz-Pamplona, Rebeca, Berdiel-Acer, Mireia, Cimas, Francisco J., García, Elena, Gonçalves-Ribeiro, Samuel, Albert, Nerea, Garcia-Vicién, Gemma, Capella, Gabriel, Moreno, Victor, Salazar, Ramon, Villanueva, Alberto, Molleví, David G. · 2019 · Clinical Cancer Research

Published version of a preprint

Abstract

Purpose The aim of the study is blocking the recruitment of a protective stroma by altering the crosstalk between normal stromal cells and tumor cells for stripping tumors of the protection conferred by the microenvironment. Experimental design A transcriptomic analysis of cocultured normal colonic fibroblasts and colorectal tumor cells was performed. We focused on the study of molecules that mediate the communication between both compartments and that entail fibroblasts' activation and the alteration of the sensitivity to chemotherapy. We identified targets for the blocking of the tumor-stroma interaction. Finally, we tested, in vivo , the blockade of the tumor-stroma interaction in orthotopic models derived from patients and in models of acquired resistance to oxaliplatin. Results IL1β/TGFβ1 are the triggers for fibroblasts' recruitment and conversion into carcinoma-associated fibroblasts (CAF) in colorectal cancer. CAFs then secrete proinflammatory factors that alter sensitivity in tumor cells, activating JAK/STAT and PI3KCA/AKT pathways. Blocking such crosstalk with a neutralizing IL1β antibody and a TGFBR1 inhibitor is relieved by the TAK1-mediated activation of the noncanonical TGFβ pathway, which induces a change in the cytokine/chemokine repertoire that maintains a sustained activation of AKT in tumor cells. TAK1 plus TGFBR1 inhibition blocks IL1β/TGFβ1-mediated fibroblast activation, decreasing the secretion of proinflammatory cytokines. In turn, tumor cells became m…

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-18-3957

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 48 references

Cited by

See all 53

Metadata

Authors
Guillén Díaz-Maroto, N., Sanz-Pamplona, R., Berdiel-Acer, M., Cimas, F. J., García, E., Gonçalves-Ribeiro, S., Albert, N., Garcia-Vicién, G., Capella, G., Moreno, V., Salazar, R., Villanueva, A., & Molleví, D. G.
Affiliations
  • 1ProCURE, Program Against Cancer Therapeutic Resistance, Catalan Institute of Oncology, IDIBELL, L’Hospitalet de Llobregat, Catalonia, Spain.
  • 2Biomarker and Susceptibility Unit, Program for Cancer Control and Prevention, Catalan Institute of Oncology, IDIBELL, L’Hospitalet de Llobregat, Catalonia, Spain.
  • 3German Cancer Research Center, Division of Molecular Genome Analysis, Heidelberg, Germany.
  • Institut d'Investigació Biomédica de Bellvitge (ES)
  • 4Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, L’Hospitalet de Llobregat, Catalonia, Spain.
  • 5ONCOBELL Program, IDIBELL, L’Hospitalet de Llobregat, Catalonia, Spain.
Venue
Clinical Cancer Research
Published
2019-07-15
Volume
25
Issue
14
Pages
4466-4479
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2935951460
Cited by
51
References
48
Citations by year
2026: 6 · 2025: 6 · 2024: 11 · 2023: 4 · 2022: 7 · 2021: 10 · 2020: 6 · 2019: 1
FWCI
1.99
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • RUIdeRA - Institutional University Repository (University of Castilla-La Mancha) (submittedVersion, other-oa)
Funders
  • Fondo de Investigaciones Sanitarias (PI10/1604)
  • FEDER (SGR771, PI10/1604, PI15/0232)
  • Department of Health of the Generalitat de Catalunya (SLT002/16/00399)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Keywords
colorectal cancer, tumor microenvironment, tumor-stroma interactions, cancer-associated fibroblasts, TAK1 inhibition, chemoresistance, oxaliplatin resistance, Akt activation, JAK/STAT signaling, PI3K/Akt signaling, fibroblast recruitment, metastasis, chemoprotection
MeSH terms
Cancer-Associated Fibroblasts, Oxaliplatin, Receptor, Transforming Growth Factor-beta Type I, MAP Kinase Kinase Kinase 7, Animals, Antineoplastic Agents, Cell Survival, Humans, Mice, Inbred Strains, Mice, Nude, Colorectal Neoplasms, Signal Transduction, Stromal Cells, Coculture Techniques, MAP Kinase Kinase Kinases, Xenograft Model Antitumor Assays, Cell Line, Tumor, Cell Proliferation, Mice, Interleukin-1beta, Transforming Growth Factor beta1, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-18-3957
The paper
Guillén Díaz-Maroto, N., Sanz-Pamplona, R., Berdiel-Acer, M., Cimas, F. J., García, E., Gonçalves-Ribeiro, S., Albert, N., Garcia-Vicién, G., Capella, G., Moreno, V., Salazar, R., Villanueva, A., & Molleví, D. G. (2019). Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-18-3957

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.